Exelixis Announces Settlement of CABOMETYX® (cabozantinib) Patent Litigation with Cipla Limited and Cipla USA : vimarsana.com

Exelixis, Inc. today announced that it has entered into a Settlement and License Agreement with Cipla Ltd. and Cipla USA, Inc. . This settlement resolves two patent litigations brought by Exelixis...

Related Keywords

Delaware , United States , , Drug Administration , Us District Court , Exchange Commission , Facebook , Us Department Of Justice , Cipla , Cipla United States Inc , Nasdaq , Cipla Ltd , Us Federal Trade Commission , Exelixis Inc , License Agreement , Cipla United States , Abbreviated New Drug Application , Civil Action , Trade Commission , Annual Report , Quarterly Reports ,